Skip to main content
DYN filings

Corporate insider profile

Jason P Rhodes Filing Activity

Latest reported as Director of Dyne Therapeutics, Inc. (DYN).

Purchase filings
0
Reported companies
1
Net open-market value
-$35,339,859.15
Latest transaction
Jun 25, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 25, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale267,760$21.09$5,646,496
May 6, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale106,723$18.14$1,936,339
Apr 28, 2026Dyne Therapeutics, Inc. (DYN)DirectorSale227,337$18.38$4,178,522